C2 and COVID-19: In particular, a strong interaction of KIR2DL1 and HLA-C2 ligands seems to promote the large and stable expansion of adaptive NK cells in human CMV infection (Manser et al., 2019), as observed in this study of COVID-19 patients with fatal outcomes.